Financial Counselors Inc Edwards Lifesciences Corp Transaction History

Financial Counselors Inc

$6.5 Billion
Q1 2025

A detailed history of Financial Counselors Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Financial Counselors Inc holds 4,645 shares of EW stock, worth $358,547. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,645

Previous 4,574 1.55%

Holding current value

$358,547

Previous $338,000 0.59%

% of portfolio

0.01%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$67.95 - $76.19 $4,824 - $5,409	71 Added 1.55%	4,645 $336,000
Q4 2024 Feb 11, 2025	BUY	$64.54 - $75.92 $6,324 - $7,440	98 Added 2.19%	4,574 $338,000
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $22,924 - $36,011	-384 Reduced 7.9%	4,476 $295,000
Q2 2024 Aug 01, 2024	SELL	$84.3 - $94.31 $180,570 - $202,012	-2,142 Reduced 30.59%	4,860 $448,000
Q1 2024 May 02, 2024	SELL	$72.54 - $95.56 $72,467 - $95,464	-999 Reduced 12.49%	7,002 $669,000
Q4 2023 Jan 26, 2024	SELL	$61.71 - $77.76 $469,119 - $591,131	-7,602 Reduced 48.72%	8,001 $610,000
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $3.89 Million - $5.24 Million	-56,157 Reduced 78.26%	15,603 $1.08 Million
Q2 2023 Jul 27, 2023	BUY	$81.41 - $94.33 $1.53 Million - $1.77 Million	18,816 Added 35.54%	71,760 $6.77 Million
Q1 2023 May 02, 2023	SELL	$74.26 - $84.51 $168,570 - $191,837	-2,270 Reduced 4.11%	52,944 $4.38 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $124,579 - $159,490	-1,824 Reduced 3.2%	55,214 $4.12 Million
Q3 2022 Nov 01, 2022	BUY	$82.37 - $107.29 $221,575 - $288,610	2,690 Added 4.95%	57,038 $4.71 Million
Q2 2022 Aug 02, 2022	BUY	$86.5 - $128.27 $4,584 - $6,798	53 Added 0.1%	54,348 $5.17 Million
Q1 2022 Apr 28, 2022	BUY	$101.96 - $128.34 $109,199 - $137,452	1,071 Added 2.01%	54,295 $6.39 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $155,300 - $190,792	1,460 Added 2.82%	53,224 $6.9 Million
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $350,820 - $418,454	-3,409 Reduced 6.18%	51,764 $5.86 Million
Q2 2021 Aug 03, 2021	BUY	$83.84 - $104.76 $275,749 - $344,555	3,289 Added 6.34%	55,173 $5.71 Million
Q1 2021 Apr 29, 2021	BUY	$78.68 - $90.67 $356,420 - $410,735	4,530 Added 9.57%	51,884 $4.34 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $144,598 - $184,010	2,017 Added 4.45%	47,354 $4.32 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $264,930 - $344,775	3,943 Added 9.53%	45,337 $3.62 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $1.67 Million - $2.23 Million	29,003 Added 234.07%	41,394 $2.86 Million
Q1 2020 Apr 23, 2020	BUY	$52.41 - $81.0 $16,928 - $26,163	323 Added 2.68%	12,391 $2.34 Million
Q4 2019 Jan 31, 2020	SELL	$71.7 - $82.09 $8,747 - $10,014	-122 Reduced 1.0%	12,068 $2.82 Million
Q3 2019 Nov 08, 2019	SELL	$61.55 - $75.43 $42,161 - $51,669	-685 Reduced 5.32%	12,190 $2.68 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $32,663 - $37,744	-586 Reduced 4.35%	12,875 $2.38 Million
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $10,679 - $14,283	223 Added 1.68%	13,461 $2.58 Million
Q4 2018 Feb 01, 2019	BUY	$46.41 - $56.94 $1,949 - $2,391	42 Added 0.32%	13,238 $2.03 Million
Q3 2018 Oct 30, 2018	BUY	$45.7 - $58.03 $14,578 - $18,511	319 Added 2.48%	13,196 $2.3 Million
Q2 2018 Aug 03, 2018	BUY	$42.45 - $51.3 $13,286 - $16,056	313 Added 2.49%	12,877 $1.88 Million
Q1 2018 Apr 26, 2018	SELL	$37.19 - $47.45 $29,937 - $38,197	-805 Reduced 6.02%	12,564 $1.75 Million
Q4 2017 Feb 12, 2018	BUY	$33.79 - $39.39 $25,747 - $30,015	762 Added 6.04%	13,369 $1.51 Million
Q3 2017 Nov 13, 2017	SELL	$36.29 - $38.83 $50,515 - $54,051	-1,392 Reduced 9.94%	12,607 $1.38 Million
Q2 2017 Aug 10, 2017	BUY	N/A	13,999	13,999 $1.66 Million

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

484M

Call Options Held

2.77M

Put Options Held

2.01M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Edwards Lifesciences Corp Transaction History